banner

Stock Chart Videos back to homepage

Daqo New Energy ($DQ) Stock Chart Analysis Video(0)

On a long downtrend from over $13 per share, the Daqo New Energy Corporation (NYSE: DQ) chart may be trying to finally form a bottom. The MACD has a solid positive divergence going with the PPS and will be watched to make a new higher low and potentially break through zero (the money line) as the candles now face a resistance point around $1.75. Bottom support is Read More

Bounce Play Potential: Hyperdynamics (HDY)(1)

For those who love the bottom plays, Hyperdynamics Corp. (NYSE: HDY) is hitting the watchlist for today. The chart is oversold and has lost a good portion of its value recently. Only the most brief of fundamental due diligence has been performed, the chart has only been assessed for a potential technical correction. Read More

Cord Blood America Stock Chart Analysis Video Cord Blood America Stock Chart Analysis Video(0)

The Cord Blood America, Inc. (OTCBB:CBAI) chart has a history of making large moves in a short time frame.  A double bottom pattern is forming as volume is increasing which will catch the eyes of traders in this popular stock.  Bottom support is intact at $0.015. Read More

Save the World Air Stock Chart Analysis Video(0)

The Save the World Air, Inc. (STWA) (OTCBB:ZERO) stock chart is making a cup and handle pattern and looking to break-out through resistance. Volume increased in the last three trading days (typically light volume days with Christmas coming), giving hints that the chart may continue its bullish ways to challenge resistance near 50 cents. Read More

Sirius XM Radio Stock Chart Analysis Video(0)

The Sirius XM Radio, Inc. (SIRI) stock chart has made an inverted head and shoulders pattern. Support is at $1.60 from the shoulders and resistance is at $1.95. A breakout of the pattern could test old highs around $2.45. The price per share is still bullish by holding over the 50 day simple moving average, which has turned slightly to trend upward towards a possible Golden Cross of the 200 day simple moving average. Read More

3DIcon Corporation Stock Chart Analysis Video(0)

The stock chart for 3DIcon Corporation (OTCBB: TDCP) has been struggling to find a bottom, but is making new higher lows over the last two months. Support is established at one cent with the break of that resistance on yesterday’s strong 40 percent climb. Technical traders will be watching for Read More

Li-ion Motors Corp. Stock Chart Analysis Video(0)

The stock chart for Li-ion Motors Corporation (OTCBB: LMCO) made a sharp climb off bottom support at a nickel to move to 15 cents over the last couple weeks. A mild retrace happened and now another push could be in the making. Shares closed at 16 cents yesterday as the indicators are holding bullish Read More

Business Continuity Solutions Stock Chart Analysis Business Continuity Solutions Stock Chart Analysis(0)

A strong chart climbing from a penny to 9 cents over the last year, Business Continuity Solutions, Inc. (Pink Sheets: BUCS) is holding the majority of the gains in the area of 7 cents presently.  A solid support is set at Read More

Vicor Technologies Stock Chart Analysis Video Vicor Technologies Stock Chart Analysis Video(0)

Vicor Technologies Inc. (OTCBB:VCRT) closed last week with a nice up day on Friday, closing up 5.76 percent at $0.0312.  There is a strong positive divergence happening with the MACD and the price per share which could be signaling a bottom for the chart.  Support is at $0.025 and resistance is initially set at $0.035, but not heavy again until $0.05.

News has been scarce for Vicor as the company has not released any significant press since the end of July 2011 when it disclosed a new agreement with ZOLL Medical Corporation.  The agreement allows ZOLL to incorporate Vicor’s patented, proprietary PD2i® nonlinear algorithm into ZOLL products to enable the ability to predict the risk of future serious events, such as sudden or imminent death in specific patient populations.




Vicor Technologies is a biotechnology company focused on the commercialization of its PD2i Analyzer™, an innovative, non-invasive diagnostic employing Vicor’s patented, proprietary PD2i® nonlinear algorithm. Clinical use of the PD2i Analyzer™ is supported by an expanding body of literature documenting the PD2i® nonlinear algorithm as a valid metric for risk stratifying specific target populations for future pathological events, including cardiovascular disease patients for death resulting from arrhythmia or congestive heart failure, diabetics for the presence of diabetic autonomic neuropathy (DAN), trauma victims for imminent death absent immediate lifesaving intervention, and ICU patients for mortality risk stratification.

Vicor Technologies (VCRT) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Universal Capital Management Stock Chart Analysis Video Universal Capital Management Stock Chart Analysis Video(0)

A thinly-traded stock with a miniscule float, the Universal Capital Management Inc. (OTCQB:UCMT) stock chart has been on a solid climb for more than a month. Recently touching 24 cents and making a new high, the UCMT chart is staying on the watchlist for continued upward pressure.

The Company announced yesterday that it filed Form N-54C with the Securities and Exchange Commission to withdraw its election to be treated as a business development company (“BDC”) under the Investment Company Act of 1940. As such, the company is no longer subject to regulation as an “investment company” under the Investment Company Act of 1940; but the company will continue to maintain its registration under the 1934 Act and will continue to be obligated to file regular reports as required.



Universal Capital Management is currently pursuing a business model whereby it serves as a direct response management and marketing company that provides management, accounting and marketing services to its outside clients.

Universal Capital Management (UCMT) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received a payment of one hundred dollars for the video analysis of the Universal Capital Management Inc stock chart from IRPRO2.0, Inc. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.